BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9627741)

  • 1. Is P50 suppression a measure of sensory gating in schizophrenia?
    Jin Y; Bunney WE; Sandman CA; Patterson JV; Fleming K; Moenter JR; Kalali AH; Hetrick WP; Potkin SG
    Biol Psychiatry; 1998 Jun; 43(12):873-8. PubMed ID: 9627741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensory gating in adult with attention-deficit/hyperactivity disorder: Event-evoked potential and perceptual experience reports comparisons with schizophrenia.
    Micoulaud-Franchi JA; Vaillant F; Lopez R; Peri P; Baillif A; Brandejsky L; Steffen ML; Boyer L; Richieri R; Cermolacce M; Bioulac S; Aramaki M; Philip P; Lancon C; Vion-Dury J
    Biol Psychol; 2015 Apr; 107():16-23. PubMed ID: 25766264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateralization of auditory sensory gating and neuropsychological dysfunction in schizophrenia.
    Thoma RJ; Hanlon FM; Moses SN; Edgar JC; Huang M; Weisend MP; Irwin J; Sherwood A; Paulson K; Bustillo J; Adler LE; Miller GA; Cañive JM
    Am J Psychiatry; 2003 Sep; 160(9):1595-605. PubMed ID: 12944333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory?
    Micoulaud-Franchi JA; Hetrick WP; Aramaki M; Bolbecker A; Boyer L; Ystad S; Kronland-Martinet R; Richieri R; Faget C; Faugere M; El-Kaim A; Cermolacce M; Lancon C; Vion-Dury J
    Schizophr Res; 2014 Aug; 157(1-3):157-62. PubMed ID: 24893905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the correlation between perceptual inundation caused by realistic immersive environmental auditory scenes and the sensory gating inventory in schizophrenia.
    El-Kaim A; Aramaki M; Ystad S; Kronland-Martinet R; Cermolacce M; Naudin J; Vion-Dury J; Micoulaud-Franchi JA
    Eur Psychiatry; 2015 Jul; 30(5):606-14. PubMed ID: 25700728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent domains of inhibitory gating in schizophrenia and the effect of stimulus interval.
    Hong LE; Summerfelt A; Wonodi I; Adami H; Buchanan RW; Thaker GK
    Am J Psychiatry; 2007 Jan; 164(1):61-5. PubMed ID: 17202545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
    Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
    Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients?
    Light GA; Braff DL
    Biol Psychiatry; 2000 Mar; 47(5):463-7. PubMed ID: 10704957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder.
    Cadenhead KS; Light GA; Geyer MA; Braff DL
    Am J Psychiatry; 2000 Jan; 157(1):55-9. PubMed ID: 10618013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal p50 gating in unmedicated schizophrenia outpatients.
    Arnfred SM; Chen AC; Glenthøj BY; Hemmingsen RP
    Am J Psychiatry; 2003 Dec; 160(12):2236-8. PubMed ID: 14638598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auditory sensory gating and catecholamine metabolism in schizophrenic and normal subjects.
    Waldo M; Gerhardt G; Baker N; Drebing C; Adler L; Freedman R
    Psychiatry Res; 1992 Oct; 44(1):21-32. PubMed ID: 1461944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects.
    Ghisolfi ES; Prokopiuk AS; Becker J; Ehlers JA; Belmonte-de-Abreu P; Souza DO; Lara DR
    Neuropsychopharmacology; 2002 Oct; 27(4):629-37. PubMed ID: 12377399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auditory verbal hallucinations in schizophrenia correlate with P50 gating.
    Smith DM; Grant B; Fisher DJ; Borracci G; Labelle A; Knott VJ
    Clin Neurophysiol; 2013 Jul; 124(7):1329-35. PubMed ID: 23490551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
    Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
    Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of auditory sensory gating in schizophrenic patients after a brief period for sleep.
    Griffith JM; Waldo M; Adler LE; Freedman R
    Psychiatry Res; 1993 Oct; 49(1):29-39. PubMed ID: 8140180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological correlates of P50 sensory gating in patients with schizophrenia.
    Sánchez-Morla EM; Santos JL; Aparicio A; García-Jiménez MÁ; Soria C; Arango C
    Schizophr Res; 2013 Jan; 143(1):102-6. PubMed ID: 23148896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Startle Modification and P50 Gating in Schizophrenia Patients and Controls: Russian Population.
    Storozheva ZI; Kirenskaya AV; Novototsky-Vlasov VY; Telesheva KY; Pletnikov M
    Span J Psychol; 2016 Mar; 19():E8. PubMed ID: 26936103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis.
    Olincy A; Martin L
    Am J Psychiatry; 2005 Jan; 162(1):43-9. PubMed ID: 15625200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory impairment and auditory evoked potential gating deficit in schizophrenia.
    Hsieh MH; Liu K; Liu SK; Chiu MJ; Hwu HG; Chen AC
    Psychiatry Res; 2004 Feb; 130(2):161-9. PubMed ID: 15033186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.